000 | 01919 a2200541 4500 | ||
---|---|---|---|
005 | 20250511182911.0 | ||
264 | 0 | _c19921123 | |
008 | 199211s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.1992.10.11.1696 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaminski, M S | |
245 | 0 | 0 |
_aImaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 1992 |
||
300 |
_a1696-711 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntigens, CD _ximmunology |
650 | 0 | 4 | _aAntigens, Neoplasm |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycoproteins _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
650 | 0 | 4 |
_aLymphoma, B-Cell _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRadiation Dosage |
650 | 0 | 4 |
_aRadioimmunotherapy _xadverse effects |
650 | 0 | 4 | _aRadionuclide Imaging |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aTetraspanins |
650 | 0 | 4 | _aTomography, X-Ray Computed |
700 | 1 | _aFig, L M | |
700 | 1 | _aZasadny, K R | |
700 | 1 | _aKoral, K F | |
700 | 1 | _aDelRosario, R B | |
700 | 1 | _aFrancis, I R | |
700 | 1 | _aHanson, C A | |
700 | 1 | _aNormolle, D P | |
700 | 1 | _aMudgett, E | |
700 | 1 | _aLiu, C P | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 10 _gno. 11 _gp. 1696-711 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1992.10.11.1696 _zAvailable from publisher's website |
999 |
_c1409543 _d1409543 |